1. Catalogs
  2. Eppendorf SE
  3. Shift the Paradigm
video corpo

Shift the Paradigm

Shift the Paradigm
1 / 16 PagesView full catalog

Shift the Paradigm

Product catalog summary
Introduction to CAR-T Cells: Chimeric Antigen Receptor (CAR)-T cells are a breakthrough in cell therapy, particularly for cancer and autoimmune diseases. They have shown effectiveness in treating certain blood cancers and hold potential for autoimmune diseases and solid tumors. The therapy aims to enhance efficacy, minimize side effects, and improve patient outcomes.
CAR-T Cell Development Process: The development process includes designing the CAR encoding vector, transducing CAR into isolated T cells, injecting CAR-T cells into patients, binding CAR-T cells to cancer cells, and destroying cancer cells. CAR-T cells are categorized into autologous (patient-derived) and allogenic (off-the-shelf solutions), each with unique challenges.
Advancements in CAR-T Cell Research: The process involves PBMC isolation, T cell enrichment, CAR transduction, and T cell activation. Technologies like the Centrifuge 5910 Ri and CellXpert® C170i optimize these processes by ensuring reproducible isolation and safe culturing of cells.
Large-Scale Production and Storage: This includes CAR-T cell harvest, expansion, and freezing. Equipment like the CellXpert CS220 and DASbox® Mini Parallel Bioreactor System ensure optimal conditions for cell culture and expansion. The Safe Code system aids in reliable sample storage.
Viral Vector Development: This involves CAR design, cloning, and amplification for lentiviral vector production. Technologies like the Innova® S44i and Mastercycler® X50 enhance plasmid yields and PCR efficiency. The BioFlo® 320 Bioprocess Controller supports scalable virus production.
Purification and Storage: The Ultracentrifuge CP100NX and Safe Code Cold Storage systems ensure high-quality purification and secure storage of vectors.
Supporting Technologies: Various Eppendorf products like the ThermoMixer® C, ep Dualfilter T.I.P.S.®, and Xplorer® electronic pipettes enhance the reliability and efficiency of CAR-T cell research and production.
Maintenance and Qualification Services: Eppendorf offers services to ensure instruments are maintained and qualified according to specifications, supporting reliable experimental data.
Sustainability Initiatives: Eppendorf is committed to sustainability, focusing on reducing CO2 emissions, minimizing waste, ensuring social compliance, and promoting social wellbeing.
Application Note 411: Lentiviral Vector Production
Abstract: Lentiviral vectors (LVs) are promising for gene therapy but face production challenges with traditional culture methods. This note describes a successful setup using HEK 293T cells on Fibra-Cel® disks in a BioBLU 5p Single-Use Vessel, achieving high titers and particle counts comparable to conventional methods.
Application Note 453: CD4+ T Cells Expansion
Abstract: T cells are crucial for adoptive cell therapy. This study evaluates the BioBLU® 0.3c Single-Use Bioreactors for CD4+ T cell expansion, showing that lower dissolved oxygen levels may enhance proliferation.
Application Note 303: rAAV Production in Sf9/BEV System
Abstract: Gene therapy for single-gene disorders often uses rAAV vectors. This note discusses a scale-down model for rAAV production using Sf9 cells, facilitating efficient process development.
Application Note 407: rAAV Production in CAP GT® Cells
Abstract: The demand for scalable viral vector production is rising. This study scales up rAAV production from shake flasks to stirred-tank bioreactors, maintaining consistent growth and production.
Application Note 450: AAV Production in Suspension Culture
Abstract: Suspension cell culture offers advantages for vaccine production. This note demonstrates a scalable AAV production platform using suspension-adapted HEK293 cells, achieving high yields.
Overview of CAR T-Cell Therapy Challenges: CAR T-cell therapies show promise in oncology but face significant limitations that hinder widespread use. Challenges include the functional fitness of patient-derived T-cells, risks of graft-versus-host disease with allogenic materials, and issues with efficacy in treating solid tumors.
Gene Editing Solutions: Research focuses on eliminating T-cell receptor (TCR) expression in CAR T-cells using gene editing tools like Zinc Finger Nucleases, TALEN, and CRISPR-Cas9 to address GvHD. Other strategies include eliminating HLA molecules and developing tumor site-specific activation methods.
Additional Challenges: CAR T therapy struggles with antigen escape and high relapse rates post-therapy.
Related Literature and Solutions: The document references various application notes and solutions related to viral vector production and cell culture processes, highlighting ongoing efforts to optimize CAR T-cell therapy production and efficacy.
See more

Catalog excerpts

Shift the Paradigm-1

Best-fit solutions for CAR-T cell research and development

 Open the catalog to page 1
Shift the Paradigm-3

CAR-T Cells: Breakthroughs in Cancer and Autoimmune Therapies One of the most revolutionary cell therapies to transition from bench to bedside in the past decade is undoubtedly the development of chimeric antigen receptor (CAR)-T cells. Here, CAR-T cells have found a plethora of different applications. Firstly, by proving to be an effective treatment for certain blood cancers that were previously deemed incurable. Secondly, in holding promise for treating certain auto-immune diseases and solid tumours. As ongoing research broadens the applications of CAR-T cells, the potential for transformative...

 Open the catalog to page 3
Shift the Paradigm-4

Designing of CAR encoding vector CAR transduction into isolated T cells Injection of CAR-T cells into patient Binding of CAR-T cell to cancer cell Destruction of cancer cell

 Open the catalog to page 4
Shift the Paradigm-5

CAR-T Cell Development – The Future of Fighting Cancer CAR-T cells, genetically engineered and equipped with specific receptors to target and combat cancer cells, are primarily divided into two categories: autologous and allogenic CAR-T cells. Hereby, autologous CAR-T cells derive from the patient’s own white blood cells and are reintroduced after modification, whereas allogenic CAR-T cells are designed as off-the-shelf solutions for use in different patients. However, both approaches have their challenges. The manufacturing process for autologous CAR-T cells is complex and costly, as each patient’s...

 Open the catalog to page 5
Shift the Paradigm-6

Advancing CAR-T Cell Research: From PBMC Isolation to Lar Safe and consistent culturing of cells Ensure optimal activation of T-Cells with the uniform atmosphere of the CellXpert® C170i. Fanless design, seamless chamber, 180 °C sterilization cycle, and a removable water tray for reliable contamination control. Reproducible PBMC isolation The Centrifuge 5910 Ri has soft acceleration/break ramps for optimized PBMC isolation and significant time savings during Ficoll gradient separation. High throughput with up to 4 × 1,000 mL working volume ideal for cell harvesting on the benchtop. 1 PBMC isolation...

 Open the catalog to page 6
Shift the Paradigm-7

rge-Scale Production Best conditions for your mammalian suspension cell culture! The CellXpert CS220 ensures precise temperature and CO₂ control, minimized evaporation by active humidity control and reliable shaking. The stainless steel chamber and integrated 180 °C sterilization protect your cells from contaminations. Reliable and traceable sample storage Freeze down your CAR-T cells and digitally store data (donor, date, CAR contstruct etc.) with the Safe Code system to readily access sample information even after transfer to LN2 (compatible with any barcode scanner). Freezing down of samples...

 Open the catalog to page 7
Shift the Paradigm-8

Viral Vector Development – from cloning to transduction Countless PCRs in as little as 15 mins The Mastercycler® X50 with the 384-well or 96-well silver block can process hundreds of PCRs in as little as 40 min and with a fast polymerase kit even in less than 15 min. Connect up to 50 devices for increased throughput. Get high plasmid yields The Innova® S44i can fit up to twice as many flasks as other shakers in the market and is ready to reliably support current high-yield plasmid production protocols at high speeds, 24/7. Cloning and amplification of plasmid system for lentiviral vector production...

 Open the catalog to page 8
Shift the Paradigm-9

Increase downstream quality and purity The Ultracentrifuge CP100NX can spin your viral vector with a maximum speed of up to 803,000 × g. Rotor life management system for increased safety! The broad rotor and adapter portfolio enables flexible vessel selection and scalability. Lentivirus vector production You need higher virus titers? The BioFlo® 320 Bioprocess Controller revolutionizes virus production by enabling higher titers with intelligent control. Achieve consistent, scalable results from R&D to full-scale through our precise, user-friendly bioreactor controller, designed for virus yield....

 Open the catalog to page 9
Shift the Paradigm-10

Centrifuge 5910 Ri > Faster PBMC isolation due to optimized acceleration and deceleration ramps for Ficoll-Paque® density gradient centrifugation > Accurate cooling with smart Dynamic Compressor Control (DCC) for optimal sample integrity. > Documentation function and user management support quality control with multiple authorization levels, password protection and documentation of all runs and user activities. > Easy cleaning, reliable contamination prevention with the fanless design, seamless chamber, 180 °C sterilization cycle, and removable water tray. > Uniform atmosphere thanks to temperature...

 Open the catalog to page 10
Shift the Paradigm-11

> Safely store up to 576 freezer boxes (740 L). Benefit of future-proof green cooling and efficient insulation > Reliably identify your valuable samples by vessel-specific barcodes, available for cryovials, tubes, and plates ep Dualfilter T. I. P. S.® ^PCR clean/sterile > Retain practically aerosols and biomolecules > Tested for filtration performance under the standard EN 29463 yielding a minimum particle collection efficiency of 99.5 % with test aerosol particles sizes of 0.05-0.5 pm. > Sterilized by electron beams, certified pyrogen-free and free from human DNA, DNase, RNase and PCR-inhibiting...

 Open the catalog to page 11
Shift the Paradigm-12

DASbox® Mini Parallel Bioreactor System > Experience precise control in a compact system with 100 mL-250 mL working volumes, ideal for cell culture and process development. > Supports up to 24 parallel bioreactors, ensuring scalability and reproducibility. > Compatible with glass and BioBLU Single-Use Bioreactors, featuring liquid-free temperature control and easy exhaust condensation handling. > Fully mass flow-controlled gas mixing with individual gas mixtures, optimizing conditions for CAR-T cell growth and viability. (CLICK <|jjMastercycler® X50s > Run time: About 40 minutes with block heating...

 Open the catalog to page 12
Shift the Paradigm-13

> Higher precision and reproducibility and an additional efficiency gain due to various operating modes (e.g. dispensing, pipetting & mixing, ...) > Extremely consistent sample pickup across all channels and user-to-user reproducibility for more consistent results. > Better results thanks to the intuitive operating concept and ergonomic design, supported by the Eppendorf PhysioCare Concept® > Use with the Pipette Manager to set up and document liquid-handling steps more quickly. Settings are instantly available on all connected electronic pipettes, avoiding setting errors. > High throughput with...

 Open the catalog to page 13
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.
About DirectIndustry
DirectIndustry is a marketplace that offers B2B players a complete experience, from product sourcing to purchase. DirectIndustry is an entity of VirtualExpo Group.